Aleksandr Nikolaevich Doronin

Title: The Innovations of Aleksandr Nikolaevich Doronin

Introduction

Aleksandr Nikolaevich Doronin is a prominent inventor based in Moscow, Russia. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 3 patents to his name, Doronin's work has the potential to impact various medical treatments.

Latest Patents

Doronin's latest patents include a monoclonal antibody that binds specifically to GITR. This invention relates to biotechnology and focuses on antibodies or antigen-binding fragments, as well as their applications. The invention also encompasses a nucleic acid encoding the antibody, an expression vector, and methods for preparing the antibody, which can be used in treating diseases associated with GITR. Another notable patent is the Anti-IL-5RAlpha monoclonal antibody, which provides antibodies that specifically bind to IL-5Rα. This disclosure includes DNA encoding the antibodies, corresponding expression vectors, and methods of production, along with treatment methods utilizing these antibodies.

Career Highlights

Throughout his career, Doronin has worked with various organizations, including Biocad, a well-known biotechnology company. His expertise in the field has allowed him to contribute to significant advancements in antibody development.

Collaborations

Doronin has collaborated with notable professionals in the field, including Valery Vladimirovich Solovyev and Dmitry Valentinovich Morozov. These collaborations have further enriched his research and innovations.

Conclusion

Aleksandr Nikolaevich Doronin's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work in monoclonal antibodies showcases the potential for advancements in medical treatments.